EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)VergleichsstudieRandomisierte kontrollierte Studie

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

Jesús San-Miguel, Binod Dhakal iD, Kwee Yong, Andrew Spencer, Sébastien Anguille, María-Victoria Mateos, Carlos Fernández de Larrea, Joaquín Martínez-López, Philippe Moreau, Cyrille Touzeau, Xavier Leleu, Irit Avivi und 31 weitere

New England Journal of Medicine · 27.07.2023 · 389 (4) · 335-347

DOI: 10.1056/nejmoa2303379 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 27.07.2023. Verfasst von Jesús San-Miguel und 42 weiteren Autor:innen. Beteiligte Einrichtung: From the Cancer Center Clínica Universidad de Navarra, Centro Investigación Medica Aplicada, Instituto de Investigación de Navarra, Centro Investigac…. Hauptthemen laut MEDLINE: Multiple Myeloma, B-Cell Maturation Antigen, Immunotherapy, Adoptive, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 852-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Janssen Research & Development, LLC, Legend Biotech USA Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaB-Cell Maturation AntigenImmunotherapy, AdoptiveAntineoplastic Agents, ImmunologicalHumansLenalidomideNeurotoxicity SyndromesProgression-Free SurvivalDrug Resistance, Neoplasm

Substanzen

cell-associated neurotoxicityLenalidomideB-Cell Maturation AntigenAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • From the Cancer Center Clínica Universidad de Navarra, Centro Investigación Medica Aplicada, Instituto de Investigación de Navarra, Centro Investigación Biomédica en Red Cáncer (CIBERONC), Pamplona (J.S.-M.), the Univer…

ORCID-Profile: Binod Dhakal, Luciano J Costa

Förderung

  • Janssen Research & Development, LLC
  • Legend Biotech USA Inc.

Zitieren

APA

San-Miguel, J., Dhakal, B., Yong, K., Spencer, A., Anguille, S., Mateos, M. V., Fernández de Larrea, C., Martínez-López, J., Moreau, P., Touzeau, C., Leleu, X., Avivi, I., Cavo, M., Ishida, T., Kim, S. J., Roeloffzen, W., van de Donk, N. W. C. J., Dytfeld, D., Sidana, S., …, & Einsele, H. (2023). Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma. New England Journal of Medicine, 389(4), 335-347. https://doi.org/10.1056/nejmoa2303379

Vancouver

San-Miguel J, Dhakal B, Yong K, Spencer A, Anguille S, Mateos MV, et al. Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma. New England Journal of Medicine. 2023;389(4):335-347. doi:10.1056/nejmoa2303379

BibTeX
@article{SanMiguel2023,
  author = {San-Miguel, Jesús and Dhakal, Binod and Yong, Kwee and Spencer, Andrew and Anguille, Sébastien and Mateos, María-Victoria and Fernández de Larrea, Carlos and Martínez-López, Joaquín and Moreau, Philippe and Touzeau, Cyrille and Leleu, Xavier and Avivi, Irit and Cavo, Michele and Ishida, Tadao and Kim, Seok Jin and Roeloffzen, Wilfried and van de Donk, Niels W C J and Dytfeld, Dominik and Sidana, Surbhi and Costa, Luciano J and Oriol, Albert and Popat, Rakesh and Khan, Abdullah M and Cohen, Yaël C and Ho, P Joy and Griffin, James and Lendvai, Nikoletta and Lonardi, Carolina and Slaughter, Ana and Schecter, Jordan M and Jackson, Carolyn C and Connors, Kaitlyn and Li, Katherine and Zudaire, Enrique and Chen, Diana and Gilbert, Jane and Yeh, Tzu-Min and Nagle, Sarah and Florendo, Erika and Pacaud, Lida and Patel, Nitin and Harrison, Simon J and Einsele, Hermann},
  title = {Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {4},
  pages = {335--347},
  doi = {10.1056/nejmoa2303379}
}
Kostenlos starten →